This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Best ETF Areas of Last Week
by Sanghamitra Saha
Last week, Wall Street snapped its nine-week win streak, marking the end of their longest consecutive weekly run in the green since 2004.
Cannabis ETFs Spike on Marijuana Classification Review
by Sweta Killa
Marijuana stocks spiked following the report that the US Drug Enforcement Administration (¿¿¿DEA¿¿¿) is reviewing the potential reclassification of cannabis from Schedule I to Schedule III.
5 Best-Performing ETFs of Last Week
by Sanghamitra Saha
Wall Street was moderately upbeat last week and exhibited a decent Santa Clause rally.
Best ETF Areas of Last Week
by Sanghamitra Saha
Wall Street delivered a decent performance last week.
5 ETF Areas That Spooked Investors in October
by Sanghamitra Saha
After a downbeat September, October too remained volatile for Wall Street due to higher rates.
The Zacks Analyst Blog Highlights MLPO, MSOS, URNJ, XES and EVXX
by Zacks Equity Research
MLPO, MSOS, URNJ, XES and EVXX are part of the Zacks top Analyst Blog.
5 Sector ETFs That Beat the Market in Q3
by Sweta Killa
After a solid start to the third quarter, Wall Street lost momentum on fears of higher rates for a longer-than-expected period and a slowing Chinese economy.
Behind the Recent Surge in Marijuana ETFs
by Sanghamitra Saha
In a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.
Best ETF Areas of Last Week
by Sanghamitra Saha
Wall Street delivered an upbeat performance last week, with the Dow Jones logging the best week since July.
Cannabis ETFs Soar on Hopes of Federal Legalization
by Sweta Killa
Marijuana stocks have been surging following a proposal by the Drug Enforcement Agency (???DEA???) to reclassify cannabis as a substance with reduced risk, fueling anticipation of federal legalization.
Cannabis ETFs Surge on Legalization Hopes: More Run Ahead?
by Sanghamitra Saha
The prospect of marijuana reclassification has injected newfound optimism into the cannabis investment landscape.
Bidenomics Divulged: ETFs in Focus
by Sanghamitra Saha
Circumnavigate the transformative path of Bidenomics -- the Presidential economic strategy -- seeking to reshape the U.S. economy in favor of the environment, labor, and manufacturing revival.
The Zacks Analyst Blog Highlights iPatha.B Sugar Subindex TR ETN, Sprott Junior Uranium Miners ETF, Bitwise Bitcoin Strategy Optimum Roll ETF, Advisorshares Pure US Cannabis ETF and KrraneShares Global Carbon Offset Strategy ETF
by Zacks Equity Research
iPatha.B Sugar Subindex TR ETN, Sprott Junior Uranium Miners ETF, Bitwise Bitcoin Strategy Optimum Roll ETF, Advisorshares Pure US Cannabis ETF and KrraneShares Global Carbon Offset Strategy ETF are included in this Analyst Blog.
Top-Performing ETF Areas of Last Week
by Sanghamitra Saha
Wall Street offered a moderate performance last week. Sugar, uranium miner, bitcoin miner, cannabis and carbon offset strategy companies topped the list.
ETFs to Play Biden's 2024 Reelection Campaign Launch
by Sanghamitra Saha
President Joe Biden recently announced his reelection bid. These ETF areas may benefit on that campaign launch.
SAFE Banking Act Resurgence Boosts Pot ETFs: A New Era Ahead?
by Sanghamitra Saha
A fresh wave of investment opportunities emerges as the SAFE Banking Act is reintroduced to Congress, promising brighter prospects for marijuana stocks and ETFs.
Zacks Investment Ideas feature highlights: Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF
by Zacks Equity Research
Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF have been highlighted in this Investment Ideas article.
Pot Stocks Surge on SAFE Banking Act Reintroduction
by Bryan Hayes
Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.
Top-Performing ETF Areas of Last Week
by Sanghamitra Saha
Wall Street delivered a mixed performance last week. Mixed tech earnings and a 25-bp Fed rate hike were the key highlights.
Pot Stocks Get Smoked: What's Behind the Move?
by Andrew Rocco
Marijuana-related stocks reversed gains from earlier in the week as revelations emerged that a recent marijuana bill is unlikely to pass.
Top ETF Stories of October
by Sanghamitra Saha
Wall Street was upbeat in October with major key U.S. indexes offering massive gains, except for the Nasdaq, which recorded muted gains.
Top-Performing ETF Areas of Last Week
by Sanghamitra Saha
Some upbeat earnings and the likelihood of slower Fed rate hikes from December boosted Wall Street last week.
Cannabis ETFs Trending Up to Start Q4
by Sweta Killa
Cannabis stocks and ETFs gained momentum to start the fourth quarter thanks to President Joe's announcement of a historic marijuana reform.
Top-performing ETF Areas of Last Week
by Sanghamitra Saha
Marijuana, oil and inverse Tesla ETFs offered outstanding gains last week.
Roundhill's Cannabis ETF (WEED) Launch Seems Timely
by Sanghamitra Saha
Roundhill Investments recently announced the launch of its own cannabis ETF, namely Roundhill Cannabis ETF (WEED).